LicianPro

Immunocore Holdings plc ·

IMCR 8-K 2026-09-14

Immunocore Holdings plc (IMCR) 8-K dated 2026-09-14 — accession 0001671927-26-000026.

Immunocore Holdings plc (IMCR) is a biotechnology company listed on NASDAQ.

Immunocore Holdings plc filed a 8-K on 2026-09-14. Accession 0001671927-26-000026.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IMCR revenue for 2025-12-31 was $400.0M. Net income was -$35.5M. Revenue was up 29.0% from 2024-12-31 to 2025-12-31. IMCR currently screens at market cap $1.45B.

Not investment advice. The IMCR SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr